Primary biliary cirrhosis: A Mount Sinai perspective

Mount Sinai Journal of Medicine

Volumn 70, Issue 4, 2003, Pages 242-250

  Bach, Nancy ^a   Odin, Joseph A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Autoantibody; Celiac disease; Cholangiocytes; Genetics; Methotrexate; Primary biliary cirrhosis; Protein oxidation; Pyruvate dehydrogenase

Indexed keywords

AUTOANTIGEN; AZATHIOPRINE; CHLORAMBUCIL; CYCLOSPORIN; METHOTREXATE; PENICILLAMINE; PREDNISOLONE; URSODEOXYCHOLIC ACID; ANTIGEN; AUTOANTIBODY;

ALOPECIA; COUGHING; DISEASE COURSE; DRUG EFFICACY; DRUG TOLERABILITY; DYSPNEA; HEALTH CENTER; HEALTH PROGRAM; HISTOPATHOLOGY; HISTORY; HUMAN; IMMUNOPATHOGENESIS; INTRAHEPATIC BILE DUCT; LIVER TRANSPLANTATION; MEDICAL SCHOOL; NAUSEA; OSTEOLYSIS; PRIMARY BILIARY CIRRHOSIS; REVIEW; STOMATITIS; UNITED STATES; APOPTOSIS; AUTOIMMUNE DISEASE; BILIARY CIRRHOSIS; BLOOD; GENETICS; IMMUNOLOGY;

ANTIGENS; APOPTOSIS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; HUMANS; LIVER CIRRHOSIS, BILIARY;

EID: 0142092736     PISSN: 00272507     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Kaplan MM. Primary biliary cirrhosis. N Engl J Med 1996; 335(21):1570-1580.
2. Culp KS, Fleming CR, Duffy J, et al. Autoimmune associations in primary biliary cirrhosis. Mayo Clin Proc 1982; 57:365-370.
3. Shapiro, JM, Smith H, Schaffner F. Serum bilirubin: a prognostic factor in primary biliary cirrhosis. Gut 1979; 20:137-140.
4. Dickson ER, Grambsch PM, Fleming TR, et al. Prognosis in primary biliary cirrhosis: model for decision making. Hepatology 1989; 10:1-7.
5. Combes B, Carithers RL, Jr., Maddrey WC, et al. A randomized, double blind placebo controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology 1995; 22:759-66.
6. Poupon RE, Poupon R, Balkan B. Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group. N Engl J Med 1994; 330:1342-1347.
7. Heathcote EJ, Cauch-Dudek K, Walker V, et al. The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology 1994; 19:1149-1156.
8. Lindor KD, Dickson ER, Baldus WP, et al. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology 1994; 106:1284-1290.
9. Verma A, Jazrawi RP, Ahmed HA, et al. Optimum dose of ursodeoxycholic acid in primary biliary cirrhosis. Eur J Gastroenterol Hepatol 1999; 11:1069-1076.
10. Angulo P, Dickson ER, Therneau TM, et al. Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial. J Hepatol 1999; 30:830-835.
11. Poupon RE, Bonnand AM, Chretien Y, Poupon R. Ten-year survival in ursodeoxycholic acid- treated patients with primary biliary cirrhosis. The UDCA-PBC Study Group. Hepatology 1999; 29:1668-1671.
12. Poupon R, Poupon RE. Treatment of primary biliary cirrhosis [review]. Baillieres Best Pract Res Clin Gastroenterol 2000; 14(4):615-628.
13. Kaplan MM, Knox TA. Treatment of primary biliary cirrhosis with low-dose methotrexate. Ann Intern Med 1988; 109:429-430.
14. Bach N, Bodian C, Bodenheimer H, Jr., et al. Methotrexate therapy for primary biliary cirrhosis. Am J Gastroenterol 2003; 98:1-7.
15. Gershwin ME, Mackay IR, Sturgess A, Coppel RL. Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis. J Immunol 1987; 138:3525-3531.
16. Yeaman SJ, Fussey SP, Danner DJ, et al. Primary biliary cirrhosis: identification of two major M2 mitochondrial autoantigens. Lancet 1988; 1:1067-1070.
17. Surh CD, Coppel R, Gershwin ME. Structural requirement for autoreactivity on human pyruvate dehydrogenase-E2, the major autoantigen of primary biliary cirrhosis. Implication for a conformational autoepitope. J Immunol 1990; 144:3367-3374.
18. Van de Water J, Ansari AA, Surh CD, et al. Evidence for the targeting by 2-oxo-dehydrogenase enzymes in the T cell response of primary biliary cirrhosis. J Immunol 1991; 146:89-94.
19. Jones DE, Palmer JM, Yeaman SJ, et al. T cell responses to natural human proteins in primary biliary cirrhosis. Clin Exp Immunol 1997; 107:562-568.
20. Teoh KL, Mackay IR, Rowley MJ, Fussey SP. Enzyme inhibitory autoantibodies to pyruvate dehydrogenase complex in primary biliary cirrhosis differ for mammalian, yeast and bacterial enzymes: implications for molecular mimicry. Hepatology 1994; 19(4):1029-1033.
21. Shimoda S, Nakamura M, Shigematsu H, et al. Mimicry peptides of human PDC-E2 163-176 peptide, the immunodominant T-cell epitope of primary biliary cirrhosis. Hepatology 2000; 31:1212-1216.
22. Mason A, Xu L, Guo L, et al. Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders. Lancet 1998; 351:1620-1624.
23. Jones DE, Palmer JM, Yeaman SJ, et al. T cell responses to natural human proteins in primary biliary cirrhosis. Clin Exp Immunol 1997; 107:562-568.
24. Quinn J, Diamond AG, Palmer JM, et al. Lipoylated and unlipoylated domains of human PDC-E2 as autoantigens in primary biliary cirrhosis: significance of lipoate attachment. Hepatology 1993; 18:1384-1391.
25. Mendel-Hartvig I, Nelson BD, Loof L, et al. Primary biliary cirrhosis: further biochemical and immunological characterization of mitochondrial antigens. Clin Exp Immunol 1984; 62:371-379.
26. Van de Water J, Turchany J, Leung PS, et al. Molecular mimicry in primary biliary cirrhosis. Evidence for biliary epithelial expression of a molecule cross-reactive with pyruvate dehydrogenase complex-E2. J Clin Invest 1993; 91(6): 2653-2664,
27. Joplin R, Wallace LL, Johnson GD, et al. Subcellular localization of pyruvate dehydrogenase dihydrolipoamide acetyl-transferase in human intrahepatic biliary epithelial cells. J Pathol 1995; 176(4):381-390.
28. Harada K, Van de Water J, Leung PS, et al. In situ nucleic acid hybridization of pyruvate dehydrogenase complex-E2 in primary biliary cirrhosis: pyruvate dehydrogenase complex- E2 messenger RNA is expressed in hepatocytes but not in biliary epithelium. Hepatology 1997; 25:27-32.
29. Levine JS, Koh JS. The role of apoptosis in autoimmunity: immunogen, antigen and accelerant. Semin Nephrol 1999; 19:34-47.
30. Utz PJ, Hottelet M, Schur PH, Anderson P. Proteins phosphorylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematous. J Exp Med 1997; 185(5):843-854.
31. Casciola-Rosen LA, Anhalt GJ, Rosen A. DNA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis. J Exp Med 1995; 182:1625-1634.
32. Casciola-Rosen L, Andrade F, Ulanet D, et al. Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity. J Exp Med 1999; 190:815-826.
33. Casciola-Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematous are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994; 179:1317-1330.
34. Harada K, Ozaki S, Gershwin ME, Nakanuma Y. Enhanced apoptosis relates to bile duct loss in primary biliary cirrhosis. Hepatology 1997; 26(6):1399-1405.
35. Koga H, Sakisaka S, Ohishi M, et al. Nuclear DNA fragmentation and expression of Bcl-2 in primary biliary cirrhosis. Hepatology 1997; 25(5):1077-1084.
36. Graham AM, Dollinger MM, Howie SE, Harrison DJ. Bile duct cells in primary biliary cirrhosis are 'primed' for apoptosis. Eur J Gastroenterol Hepatol 1998; 10(7):553-537.
37. Olumo AM, Vickers CR, Waring RH, et al. High incidence of poor sulfoxidation in patients with primary biliary cirrhosis. N Engl J Med; 318:1089-1092.
38. Gregory WL, Mehal W, Dunn AN, et al. Primary biliary cirrhosis: contribution of HLA class II allele DR8. Q J Med 1993; 86:393-399.
39. Seki T, Kiyosawa K, Ota M, et al. Association of primary biliary cirrhosis with human leukocyte antigen DPB 1 *0501 in Japanese patients. Hepatology 1993; 18:73-78.
40. Gordon MA, Oppenheim E, Camp NJ, et al. Primary biliary cirrhosis shows association with genetic polymorphism of tumour necrosis factor alpha promotor region. J Hepatol 1999; 31:242-247.
41. Agarwal K, Jones DEJ, Bassendine MF. Genetic susceptibility to primary biliary cirrhosis. Eur J Gastroenterol Hepatol 1999; 11:603-606.
42. Bach N, Schaffner F. Familial primary biliary cirrhosis. J Hepatol 1994; 20:698-701.
43. Kim WR, Lindor KD, Locke GR, et al. Epidemiology and natural history of primary biliary cirrhosis in a US community. Gastroenterology 2000; 119:1631-1636.
44. Tsuji K, Watanabe Y, Van de Water J, et al. Familial primary biliary cirrhosis in Hiroshima. J Autoimmun 1999; 13:171-178.
45. Jones DE, Watt FE, Metcalf JV, et al. Familial primary biliary cirrhosis reassessed: a geographically-based population study. J Hepatol 1999; 30:402-407.
46. Brind AM, Bray GP, Portmann BC, Williams RF. Prevalence and pattern of familial disease in primary biliary cirrhosis. Gut 1995; 36:615-617.
47. Schussler GC, Schaffner F, Korn F. Increased serum thyroid hormone binding and decreased free hormone in chronic liver disease. N Engl J Med 1978; 299:510-515.
48. Heathcote EJ. Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines. Hepatology 2000; 31:1005-1013.
49. Kingham JG, Parker DR. The association between primary biliary cirrhosis and coeliac disease: a study of relative prevalences. Gut 1998; 42:120-122.
50. Dickey W, McMillan SA, Callender ME. High prevalence of celiac sprue among patients with primary biliary cirrhosis. J Gastroenterol 1997; 25:328-329.
51. Bardella MT, Quatrini M, Zuin M, et al. Screening patients with celiac disease for primary biliary cirrhosis and vice versa. Am J Gastroenterol 1997; 92:1524-1526.
52. Fidler HM, Butler P, Burroughs AK, et al. Co-screening for primary biliary cirrhosis and coeliac disease. Primary biliary cirrhosis and coeliac disease: a study of relative prevalences. Gut 1998; 43:300.
53. Niveloni S, Dezi R, Pedreira S, et al. Gluten sensitivity in patients with primary biliary cirrhosis. Am J Gastroenterol 1998; 93:404-408.
54. Basso D, Gallo N, Guariso G, et al. Role of anti-transglutaminase (anti-tTG), anti-gliadin, and anti-endomysium serum antibodies in diagnosing celiac disease: a comparison of four different commercial kits for anti-tTG determination. J Clin Lab Anal 2001; 15:112-115.